Primary Site >> Stomach Cancer
Gene >> UGT1A1
| 1. | |||||||||||
| Journal: | Suppl Tumori. 2003 Sep-Oct;2(5):S19-22. | ||||||||||
| Title: | Pharmacogenetics of stomach cancer. | ||||||||||
| Author: | Toffoli, Giuseppe|Cecchin, Erika | ||||||||||
| PMID: | 12914384 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncol Rep. 2009 Jul;22(1):127-36. | ||||||||||
| Title: | Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer | ||||||||||
| Author: | Seo, Bong-Gun|Kwon, Hyuk-Chan|Oh, Sung Yong|Lee, Suee|Kim, Sung-Gun|Kim, Sung-Hyun|Han, Hoon|Kim, Hyo-Jin | ||||||||||
| PMID: | 19513514 | ||||||||||
| 3. | |||||||||||
| Journal: | Ann Oncol. 2011 Apr;22(4):890-6. | ||||||||||
| Title: | Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results. | ||||||||||
| Author: | Park, S R|Kong, S-Y|Rhee, J|Park, Y-I|Ryu, K W|Lee, J H|Kim, Y-W|Choi, I J|Kim, C G|Lee, J Y|Cho, S-J|Kim, N K | ||||||||||
| PMID: | 20860988 | ||||||||||
| 4. | |||||||||||
| Journal: | Br J Cancer. 2011 Nov 8;105(10):1522-32. | ||||||||||
| Title: | An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells. | ||||||||||
| Author: | Yashiro, M|Qiu, H|Hasegawa, T|Zhang, X|Matsuzaki, T|Hirakawa, K | ||||||||||
| PMID: | 21997136 | ||||||||||
| 5. | |||||||||||
| Journal: | Br J Cancer. 2012 May 8;106(10):1591-7. | ||||||||||
| Title: | Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer. | ||||||||||
| Author: | Jo, J-C|Lee, J-L|Ryu, M-H|Chang, H M|Kim, M|Lee, H J|Kim, H-S|Shin, J-G|Kim, T-W|Kang, Y-K | ||||||||||
| PMID: | 22516947 | ||||||||||
| 6. | |||||||||||
| Journal: | Tohoku J Exp Med. 2013 Feb;229(2):107-14. | ||||||||||
| Title: | Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy. | ||||||||||
| Author: | Inoue, Kazuyuki|Sonobe, Momoyo|Kawamura, Yukinori|Etoh, Takashi|Takagi, Masakazu|Matsumura, Takashi|Kikuyama, Masataka|Kimura, Midori|Minami, Sato|Utsuki, Hiroaki|Yamazaki, Tomoaki|Suzuki, Takayo|Tsuji, Daiki|Hayashi, Hideki|Itoh, Kunihiko | ||||||||||
| PMID: | 23303296 | ||||||||||
| 7. | |||||||||||
| Journal: | Med Oncol. 2013;30(3):630. | ||||||||||
| Title: | Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients. | ||||||||||
| Author: | Gao, Jing|Zhou, Jun|Li, Yanyan|Peng, Zhi|Li, Yilin|Wang, Xicheng|Shen, Lin | ||||||||||
| PMID: | 23783485 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2013 Sep;72(3):629-35. | ||||||||||
| Title: | CPT-11 as a second-line treatment for patients with advanced/metastatic gastric cancer who failed S-1 (CCOG0702). | ||||||||||
| Author: | Mochizuki, Yoshinari|Ohashi, Norifumi|Kojima, Hiroshi|Ishigure, Kiyoshi|Kinoshita, Takashi|Eguchi, Takehiko|Fujitake, Shinichi|Ito, Seiji|Fujiwara, Michitaka|Kodera, Yasuhiro | ||||||||||
| PMID: | 23881212 | ||||||||||
| 9. | |||||||||||
| Journal: | Br J Cancer. 2013 Nov 12;109(10):2619-28. | ||||||||||
| Title: | A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma. | ||||||||||
| Author: | Yashiro, M|Nishii, T|Hasegawa, T|Matsuzaki, T|Morisaki, T|Fukuoka, T|Hirakawa, K | ||||||||||
| PMID: | 24129235 | ||||||||||
| 10. | |||||||||||
| Journal: | Tumour Biol. 2015 Aug;36(8):5831-7. | ||||||||||
| Title: | Differential expression of the UGT1A family of genes in stomach cancer tissues. | ||||||||||
| Author: | Cengiz, Beyhan|Yumrutas, Onder|Bozgeyik, Esra|Borazan, Ersin|Igci, Yusuf Ziya|Bozgeyik, Ibrahim|Oztuzcu, Serdar | ||||||||||
| PMID: | 25712374 | ||||||||||
| 11. | |||||||||||
| Journal: | Chemotherapy. 2016;61(4):197-203. | ||||||||||
| Title: | Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer. | ||||||||||
| Author: | Wang, Wenna|Huang, Jing|Tao, Yunxia|Lyu, Xiao|Yang, Lin|Wu, Dawei|Tian, Yantao | ||||||||||
| PMID: | 26872008 | ||||||||||
| 12. | |||||||||||
| Journal: | BMC Gastroenterol. 2017 Jan 5;17(1):2. | ||||||||||
| Title: | Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. | ||||||||||
| Author: | Cao, Yongkuan|Zhang, Guohu|Wang, Peihong|Zhou, Jun|Gan, Wei|Song, Yaning|Huang, Ling|Zhang, Ya|Luo, Guode|Gong, Jiaqing|Zhang, Lin | ||||||||||
| PMID: | 28056823 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncologist. 2017 Mar;22(3):293-303. | ||||||||||
| Title: | Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer. | ||||||||||
| Author: | Kim, Ji-Won|Lee, Keun-Wook|Kim, Kyu-Pyo|Lee, Ju Hyun|Hong, Yong Sang|Kim, Jeong-Eun|Kim, Sun Young|Park, Sook Ryun|Nam, Byung-Ho|Cho, Sang-Hee|Chung, Ik-Joo|Park, Young Suk|Oh, Ho-Suk|Lee, Myung-Ah|Kang, Hye Jin|Park, Young Iee|Song, Eun-Kee|Han, Hye Sook | ||||||||||
| PMID: | 28209749 | ||||||||||
| 14. | |||||||||||
| Journal: | World J Gastroenterol. 2017 Dec 28;23(48):8533-8543. | ||||||||||
| Title: | Analysis of 12 variants in the development of gastric and colorectal cancers. | ||||||||||
| Author: | Cavalcante, Giovanna C|Amador, Marcos At|Ribeiro Dos Santos, Andre M|Carvalho, Darlen C|Andrade, Roberta B|Pereira, Esdras Eb|Fernandes, Marianne R|Costa, Danielle F|Santos, Ney Pc|Assumpcao, Paulo P|Ribeiro Dos Santos, Andrea|Santos, Sidney | ||||||||||
| PMID: | 29358861 | ||||||||||